GGrantIndex
← Search

Flow Cytometry Core Shared Resource

$6,898P30FY2018CANIH

Northwestern University At Chicago, Evanston IL

Investigators

Linked publications, trials & patents

Trial NCT07639528Trial NCT07594626Trial NCT07594548Trial NCT07290543Trial NCT07261657Trial NCT07178301Trial NCT07169617Trial NCT07050186Trial NCT07042919Trial NCT06959641Trial NCT06813898Trial NCT06723457Trial NCT06630416Trial NCT06571734Trial NCT06499870Trial NCT06410248Trial NCT06327477Trial NCT06247540Trial NCT06244004Trial NCT06242834Trial NCT06184750Trial NCT06164275Trial NCT06137651Trial NCT06062498Trial NCT06060587Trial NCT06022822Trial NCT05879250Trial NCT05852041Trial NCT05802186Trial NCT05744739Trial NCT05733000Trial NCT05620771Trial NCT05576896Trial NCT05545150Trial NCT05453799Trial NCT05419011Trial NCT05411107Trial NCT05236036Trial NCT05202782Trial NCT05093387Trial NCT04931017Trial NCT04910425Trial NCT04795869Trial NCT04767984Trial NCT04753216Trial NCT04576104Trial NCT04550481Trial NCT04250051Trial NCT04227028Trial NCT04200443Trial NCT04049227Trial NCT04047706Trial NCT04033432Trial NCT04009044Trial NCT03854474Trial NCT03812562Trial NCT03742258Trial NCT03723915Trial NCT03704714Trial NCT03513484Trial NCT03317405Trial NCT03278925Trial NCT03226249Trial NCT03213041Trial NCT03146650Trial NCT03077828Trial NCT03070002Trial NCT03061188Trial NCT03048500Trial NCT03044730Trial NCT03036930Trial NCT03020017Trial NCT02993159Trial NCT02968810Trial NCT02965703Trial NCT02901899Trial NCT02892734Trial NCT02871323Trial NCT02861040Trial NCT02847559Trial NCT02837029Trial NCT02819804Trial NCT02808143Trial NCT02805868Trial NCT02794883Trial NCT02774681Trial NCT02743364Trial NCT02720484Trial NCT02694809Trial NCT02536794Trial NCT02530619Trial NCT02530502Trial NCT02530125Trial NCT02481310Trial NCT02365480Trial NCT02357810Trial NCT02314156Trial NCT02242097Trial NCT02237183Trial NCT02232516

Abstract

Sri$ ABSTRACT ? FLOW CYTOMETRY CORE FACILITY The Robert H. Lurie Comprehensive Cancer Center Flow Cytometry Core Facility provides comprehensive flow cytometry and cell sorting services for investigators of the Lurie Cancer Center and Northwestern University. Its central mission is to provide guidance, technical assistance, and equipment for investigators to utilize routine and complex multi-parametric, multi-laser measurements as well as cell sorting, regardless of their level of cytometry expertise. The Flow Cytometry Core Facility serves individuals interested in cellular-based measurements and cellular heterogeneity in malignancies, providing critical support for cancer-related research. Services provided by the facility extend from consultation on experimental design, sample preparation and data analysis to instrument operation and set-up for cell sorting and multi-laser operation. The Core also has an active program of flow cytometry protocol and assay development guided by the interests and needs of the investigators. The Core has extensive experience in developing and implementing complex multi-parametric assays with particular expertise in intracellular labile antigen detection such as phosphorylated protein epitopes. User training for operation of analysis and cell sorting instruments gives users around-the-clock access and allows the maximum use of the Core?s instruments. The Flow Cytometry Core Facility serves both the Chicago and Evanston campuses. The Chicago campus facility has 5 cell sorters: Two 5 laser/15-17 parameter BD FACSAria SORP cell sorters, a 6 laser/15-17 parameter BD FACSAria SORP cell sorter, a 3 laser/10-12 parameter BD FACSAria SORP cell sorter and a 3 laser/10 parameter BD FACSMelody cell sorter. The Chicago campus facility also has three benchtop flow cytometry analyzers; 6 laser/18 parameter BD LSRFortessa SORP, another 6 laser/18 parameter BD LSRFortessa, which is being upgraded to 30 parameters and a soon to be purchased Apogee Micro-Plus flow cytometer for small particle analysis. In addition, the Chicago facility has a Nexcelom cell counter/viability instrument (Nexcelom Bioscience, LLC). On the Evanston campus, we have one 4 laser, 13 parameter BD FACSAria IIu and a 4 laser/13 parameter BD LSRII. Both facilities have multiple offline analysis workstations providing the components and all advanced software for post-acquisition data analysis and graphics generation. The Core is heavily utilized by a wide number of investigators (207) with 63% who are Cancer Center members.

View original record on NIH RePORTER →
Flow Cytometry Core Shared Resource · GrantIndex